To include your compound in the COVID-19 Resource Center, submit it here.

Abzena, UCL deal

Abzena's Antitope Ltd. subsidiary and University College London partnered to humanize an anti- leucine-rich alpha-2-glycoprotein

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE